001367 海森药业
已收盘 02-13 15:00:00
资讯
新帖
简况
海森药业:截至2026年2月10日,公司股东总户数约为1万户
证券之星 · 02-12
海森药业:截至2026年2月10日,公司股东总户数约为1万户
海森药业:截至2026年1月31日,公司股东总户数约为1万户
证券之星 · 02-03
海森药业:截至2026年1月31日,公司股东总户数约为1万户
海森药业:截至2026年1月10日股东户数约1.04万户
证券之星 · 01-22
海森药业:截至2026年1月10日股东户数约1.04万户
海森药业:截至2026年1月10日股东户数约1.04万户
证券之星 · 01-14
海森药业:截至2026年1月10日股东户数约1.04万户
海森药业完成2025年度持续督导培训,强化规范运作意识
中金财经 · 01-06
海森药业完成2025年度持续督导培训,强化规范运作意识
海森药业部分董高减持计划实施完成,财务总监提前终止减持
中金财经 · 01-06
海森药业部分董高减持计划实施完成,财务总监提前终止减持
海森药业:12月31日高管楼岩军减持股份合计2.55万股
证券之星 · 01-05
海森药业:12月31日高管楼岩军减持股份合计2.55万股
每周股票复盘:海森药业(001367)高管连续减持股份
证券之星 · 01-03
每周股票复盘:海森药业(001367)高管连续减持股份
海森药业:12月30日高管代亚、胡康康减持股份合计3.44万股
证券之星 · 2025-12-31
海森药业:12月30日高管代亚、胡康康减持股份合计3.44万股
海森药业:12月26日高管胡康康、潘爱娟减持股份合计1.32万股
证券之星 · 2025-12-29
海森药业:12月26日高管胡康康、潘爱娟减持股份合计1.32万股
海森药业:截至2025年12月20日股东总户数约为1.1万户
证券之星 · 2025-12-23
海森药业:截至2025年12月20日股东总户数约为1.1万户
海森药业:截至2025年12月10日股东总户数约为1.1万户
证券之星 · 2025-12-16
海森药业:截至2025年12月10日股东总户数约为1.1万户
海森药业(001367.SZ)被认定为国家级专精特新小巨人企业
智通财经 · 2025-12-15
海森药业(001367.SZ)被认定为国家级专精特新小巨人企业
海森药业(001367)披露董事、高级管理人员减持股份预披露公告,12月5日股价下跌0.31%
证券之星 · 2025-12-05
海森药业(001367)披露董事、高级管理人员减持股份预披露公告,12月5日股价下跌0.31%
12月4日增减持汇总:飞沃科技等2股增持 海森药业等9股减持(表)
新浪证券 · 2025-12-04
12月4日增减持汇总:飞沃科技等2股增持 海森药业等9股减持(表)
海森药业(001367)披露完成工商变更登记并换发营业执照,12月4日股价下跌1.97%
证券之星 · 2025-12-04
海森药业(001367)披露完成工商变更登记并换发营业执照,12月4日股价下跌1.97%
海森药业:浙商资管、光大保德信基金等多家机构于12月3日调研我司
证券之星 · 2025-12-04
海森药业:浙商资管、光大保德信基金等多家机构于12月3日调研我司
海森药业:截至2025年11月30日股东户数约1.1万户
证券之星 · 2025-12-03
海森药业:截至2025年11月30日股东户数约1.1万户
海森药业(001367)披露部分募投项目结项并将节余募集资金投入新项目,11月28日股价下跌0.43%
证券之星 · 2025-11-28
海森药业(001367)披露部分募投项目结项并将节余募集资金投入新项目,11月28日股价下跌0.43%
海森药业(001367)披露部分募投项目结项并将节余募集资金投入新项目公告,10月30日股价下跌0.26%
证券之星 · 2025-10-30
海森药业(001367)披露部分募投项目结项并将节余募集资金投入新项目公告,10月30日股价下跌0.26%
加载更多
公司概况
公司名称:
浙江海森药业股份有限公司
所属行业:
医药制造业
上市日期:
2023-04-10
主营业务:
浙江海森药业股份有限公司的主营业务是化学药品原料药及中间体研发、生产和销售。公司的主要产品是化学药品原料药、中间体。公司先后获得了浙江省“专精特新”中小企业,创新型中小企业,科技型中小企业,AAA级“守合同重信用”企业,第二批制造业“云上企业”;金华市优秀企业金星奖,专利示范企业;东阳市“工业强市贡献奖”,“纳税百强”,政府质量奖等荣誉称号。
发行价格:
44.48
{"stockData":{"symbol":"001367","market":"SZ","secType":"STK","nameCN":"海森药业","latestPrice":23.8,"timestamp":1770966231000,"preClose":24,"halted":0,"volume":604633,"delay":0,"changeRate":-0.0083,"floatShares":39697700,"shares":152000000,"eps":0.8128,"marketStatus":"已收盘","change":-0.2,"latestTime":"02-13 15:00:00","open":24.12,"high":24.17,"low":23.74,"amount":14490300,"amplitude":0.0179,"askPrice":23.82,"askSize":24,"bidPrice":23.8,"bidSize":1,"shortable":0,"etf":0,"ttmEps":0.8128,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":24,"symbolType":"stock","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":26.4,"lowLimit":21.6,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":152351200,"isCdr":false,"pbRate":2.55,"roa":"--","peRate":29.281496,"roe":"6.35%","epsLYR":1.22,"committee":-0.12381,"marketValue":3626000000,"turnoverRate":0.0152,"status":1,"floatMarketCap":945000000},"requestUrl":"/m/hq/s/001367","defaultTab":"news","newsList":[{"id":"2610914947","title":"海森药业:截至2026年2月10日,公司股东总户数约为1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2610914947","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610914947?lang=zh_cn&edition=full","pubTime":"2026-02-12 15:06","pubTimestamp":1770879982,"startTime":"0","endTime":"0","summary":"证券之星消息,海森药业(001367)02月12日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 新年好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年2月10日A股股东人数是多少?谢谢海森药业回复:尊敬的投资者,您好!截至2026年2月10日,公司股东总户数约为1万户。谢谢您的关注和支持!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200018928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"gpt_icon":0},{"id":"2608840395","title":"海森药业:截至2026年1月31日,公司股东总户数约为1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608840395","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608840395?lang=zh_cn&edition=full","pubTime":"2026-02-03 15:18","pubTimestamp":1770103102,"startTime":"0","endTime":"0","summary":"证券之星消息,海森药业(001367)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问:请问1月31日公司股东人数是多少?谢谢!海森药业回复:尊敬的投资者,您好!截至2026年1月31日,公司股东总户数约为1万户。谢谢您的关注和支持!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300020230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"gpt_icon":0},{"id":"2605466582","title":"海森药业:截至2026年1月10日股东户数约1.04万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2605466582","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605466582?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:30","pubTimestamp":1769070638,"startTime":"0","endTime":"0","summary":"证券之星消息,海森药业(001367)01月22日在投资者关系平台上答复投资者关心的问题。投资者提问:请问1月10日公司股东人数是多少?谢谢!海森药业回复:尊敬的投资者,您好!截至2026年1月10日,公司股东总户数约为1.04万户。谢谢您的关注和支持!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200024742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"gpt_icon":0},{"id":"2603266741","title":"海森药业:截至2026年1月10日股东户数约1.04万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2603266741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603266741?lang=zh_cn&edition=full","pubTime":"2026-01-14 15:04","pubTimestamp":1768374260,"startTime":"0","endTime":"0","summary":"证券之星消息,海森药业(001367)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截至2026年1月10日,公司股东数是多少?海森药业回复:尊敬的投资者,您好!截至2026年1月10日,公司股东总户数约为1.04万户。谢谢您的关注和支持!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400019896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"gpt_icon":0},{"id":"2601856773","title":"海森药业完成2025年度持续督导培训,强化规范运作意识","url":"https://stock-news.laohu8.com/highlight/detail?id=2601856773","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601856773?lang=zh_cn&edition=full","pubTime":"2026-01-06 08:36","pubTimestamp":1767659762,"startTime":"0","endTime":"0","summary":"中访网数据 中信证券股份有限公司作为浙江海森药业股份有限公司的保荐机构,于2025年12月29日通过线上线下结合的方式,对公司董事、高级管理人员、部分中层以上管理人员及控股股东、实际控制人等相关人员进行了2025年度持续督导培训。中信证券在培训报告中指出,海森药业积极配合本次督导工作,培训达到了预期效果,有助于公司相关责任主体强化合规意识,促进公司健康发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260106/31917991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["001367","BK0239"],"gpt_icon":0},{"id":"2601585638","title":"海森药业部分董高减持计划实施完成,财务总监提前终止减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2601585638","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601585638?lang=zh_cn&edition=full","pubTime":"2026-01-06 08:10","pubTimestamp":1767658249,"startTime":"0","endTime":"0","summary":"中访网数据 浙江海森药业股份有限公司于近日披露了部分董事、高级管理人员股份减持计划的最新进展。与此同时,公司财务总监潘爱娟决定提前终止其减持计划,其在减持期内仅减持3,000股,剩余未减持的21,420股股份将不再根据原计划进行减持。此次减持计划的实施不会导致公司控制权发生变更,也不会对公司治理结构及持续经营产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260106/31916909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","001367"],"gpt_icon":0},{"id":"2601353886","title":"海森药业:12月31日高管楼岩军减持股份合计2.55万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601353886","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601353886?lang=zh_cn&edition=full","pubTime":"2026-01-05 20:02","pubTimestamp":1767614526,"startTime":"0","endTime":"0","summary":"证券之星消息,根据1月5日市场公开信息、上市公司公告及交易所披露数据整理,海森药业最新董监高及相关人员股份变动情况:2025年12月31日公司副总经理楼岩军共减持公司股份2.55万股,占公司总股本为0.0168%。变动期间公司股价上涨0.0%,12月31日当日收盘报21.95元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500035228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"gpt_icon":0},{"id":"2600391060","title":"每周股票复盘:海森药业(001367)高管连续减持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2600391060","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600391060?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:33","pubTimestamp":1767382390,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,海森药业报收于21.95元,较上周的22.03元下跌0.36%。本周,海森药业12月29日盘中最高价报22.1元。12月31日盘中最低价报21.79元。海森药业当前最新总市值33.44亿元,在化学制药板块市值排名126/150,在两市A股市值排名4332/5181。本周关注点股本股东变化:2025年12月30日公司董事代亚、董秘胡康康共减持3.44万股,占总股本0.0226%。股本股东变化:12月26日董秘胡康康、高管潘爱娟减持1.32万股,占总股本0.0087%。当日股价下跌0.72%,收盘价为22.03元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"gpt_icon":0},{"id":"2595771250","title":"海森药业:12月30日高管代亚、胡康康减持股份合计3.44万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595771250","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595771250?lang=zh_cn&edition=full","pubTime":"2025-12-31 21:02","pubTimestamp":1767186122,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月31日市场公开信息、上市公司公告及交易所披露数据整理,海森药业最新董监高及相关人员股份变动情况:2025年12月30日公司董事代亚、董秘胡康康共减持公司股份3.44万股,占公司总股本为0.0226%。海森药业近半年内的董监高及核心技术人员增减持详情如下:海森药业的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出539.58万,融资余额减少;融券净流入200.0,融券余额增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100042799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"gpt_icon":0},{"id":"2595078006","title":"海森药业:12月26日高管胡康康、潘爱娟减持股份合计1.32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595078006","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595078006?lang=zh_cn&edition=full","pubTime":"2025-12-29 21:02","pubTimestamp":1767013323,"startTime":"0","endTime":"0","summary":"证券之星消息,根据12月29日市场公开信息、上市公司公告及交易所披露数据整理,海森药业最新董监高及相关人员股份变动情况:2025年12月26日公司董秘胡康康、高管潘爱娟共减持公司股份1.32万股,占公司总股本为0.0087%。变动期间公司股价下跌0.72%,12月26日当日收盘报22.03元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900034967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"gpt_icon":0},{"id":"2593168493","title":"海森药业:截至2025年12月20日股东总户数约为1.1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593168493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593168493?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:54","pubTimestamp":1766480068,"startTime":"0","endTime":"0","summary":"证券之星消息,海森药业(001367)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!请问公司截至12月20日公司的股东人数是多少?谢谢海森药业回复:尊敬的投资者,您好!截至2025年12月20日,公司股东总户数约为1.1万户。谢谢您的关注和支持!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300026191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"gpt_icon":0},{"id":"2591730106","title":"海森药业:截至2025年12月10日股东总户数约为1.1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2591730106","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591730106?lang=zh_cn&edition=full","pubTime":"2025-12-16 08:39","pubTimestamp":1765845551,"startTime":"0","endTime":"0","summary":"证券之星消息,海森药业(001367)12月15日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2025年12月10日股东人数是多少?海森药业回复:尊敬的投资者,您好!截至2025年12月10日,公司股东总户数约为1.1万户。谢谢您的关注和支持!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600005961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"gpt_icon":0},{"id":"2591611661","title":"海森药业(001367.SZ)被认定为国家级专精特新小巨人企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2591611661","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591611661?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:50","pubTimestamp":1765788605,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海森药业(001367.SZ)公告,公司通过第七批专精特新“小巨人”企业认定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","399267","001367"],"gpt_icon":0},{"id":"2589895339","title":"海森药业(001367)披露董事、高级管理人员减持股份预披露公告,12月5日股价下跌0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589895339","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589895339?lang=zh_cn&edition=full","pubTime":"2025-12-05 17:50","pubTimestamp":1764928235,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘,海森药业报收于22.79元,较前一交易日下跌0.31%,最新总市值为34.72亿元。该股当日开盘22.85元,最高23.0元,最低22.33元,成交额达2402.66万元,换手率为2.68%。近日,海森药业发布关于公司董事、高级管理人员减持股份的预披露公告。减持原因为个人资金需要,股份来源为公司2024年限制性股票激励计划首次授予部分第一个解除限售期解除限售的股份。上述人员减持数量均未超过其持有股份总数的25%,减持价格将按市场价格确定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500027966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"gpt_icon":0},{"id":"2588887911","title":"12月4日增减持汇总:飞沃科技等2股增持 海森药业等9股减持(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2588887911","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588887911?lang=zh_cn&edition=full","pubTime":"2025-12-04 21:55","pubTimestamp":1764856500,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 据统计,12月4日,盘后飞沃科技、东阿阿胶披露增持情况。包括海森药业、海科新源、ST瑞和、联动科技、深科技、德艺文创、太阳电缆、中自科技、东望时代在内的9家A股上市公司披露减持情况。\n\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-04/doc-infzrzsu0235429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0259","001367","301232"],"gpt_icon":0},{"id":"2588008850","title":"海森药业(001367)披露完成工商变更登记并换发营业执照,12月4日股价下跌1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588008850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588008850?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:31","pubTimestamp":1764840676,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘,海森药业报收于22.86元,较前一交易日下跌1.97%,最新总市值为34.83亿元。公司近日发布公告称,浙江海森药业股份有限公司已于近期完成工商变更登记及《公司章程》备案手续,并取得浙江省市场监督管理局换发的营业执照。此次变更涉及注册资本调整,由“壹亿伍仟壹佰玖拾贰万陆仟肆佰肆拾元”变更为“壹亿伍仟贰佰叁拾伍万壹仟贰佰元整”。除注册资本外,营业执照其他内容未发生变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400027311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"gpt_icon":0},{"id":"2588504076","title":"海森药业:浙商资管、光大保德信基金等多家机构于12月3日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2588504076","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588504076?lang=zh_cn&edition=full","pubTime":"2025-12-04 09:16","pubTimestamp":1764811003,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年12月3日海森药业发布公告称浙商资管、光大保德信基金、中信证券于2025年12月3日调研我司。公司密切跟踪市场动态,积极协调产销衔接,以保障对客户订单的及时、充足交付。目前,公司生产经营活动按计划正常、有序开展。全年最终业绩完成情况,请以公司届时披露的定期报告为准。海森药业主营业务:从事化学药品原料药及中间体研发、生产和销售的高新技术企业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400005538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"gpt_icon":0},{"id":"2588909880","title":"海森药业:截至2025年11月30日股东户数约1.1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588909880","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588909880?lang=zh_cn&edition=full","pubTime":"2025-12-03 08:54","pubTimestamp":1764723255,"startTime":"0","endTime":"0","summary":"证券之星消息,海森药业(001367)12月02日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止到2025年11月30日,公司股东人数是多少?海森药业回复:尊敬的投资者,您好!截至2025年11月30日,公司股东总户数约为1.1万户。谢谢您的关注和支持!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300004441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"gpt_icon":0},{"id":"2586733209","title":"海森药业(001367)披露部分募投项目结项并将节余募集资金投入新项目,11月28日股价下跌0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586733209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586733209?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:40","pubTimestamp":1764340807,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘,海森药业报收于23.02元,较前一交易日下跌0.43%,最新总市值为35.07亿元。近日,浙江海森药业股份有限公司召开2025年第三次临时股东会,审议通过《关于部分募投项目结项并将节余募集资金投入新项目的议案》及《关于变更注册资本、修订<公司章程>并办理工商变更登记的议案》。出席会议股东及代理人共188人,代表有表决权股份总数的74.3464%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800040985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"gpt_icon":0},{"id":"2579537119","title":"海森药业(001367)披露部分募投项目结项并将节余募集资金投入新项目公告,10月30日股价下跌0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579537119","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579537119?lang=zh_cn&edition=full","pubTime":"2025-10-30 18:10","pubTimestamp":1761819050,"startTime":"0","endTime":"0","summary":"截至2025年10月30日收盘,海森药业报收于23.28元,较前一交易日下跌0.26%,最新总市值为35.47亿元。该股当日开盘23.36元,最高23.6元,最低23.21元,成交额达2433.78万元,换手率为2.62%。近日,海森药业发布公告称,公司将于2025年11月28日14:00召开2025年第三次临时股东会,会议将审议《关于部分募投项目结项并将节余募集资金投入新项目的议案》。该项议案涉及中小投资者利益,公司将对中小投资者的表决情况单独统计并披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000036115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1771347164238,"stockEarnings":[{"period":"1week","weight":-0.0153},{"period":"1month","weight":-0.0034},{"period":"3month","weight":-0.0083},{"period":"6month","weight":-0.1139},{"period":"1year","weight":0.3193},{"period":"ytd","weight":0.0843}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江海森药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"10000人(较上一季度增加0.00%)","perCapita":"3969股","listingDate":"2023-04-10","address":"浙江省金华市东阳市六石街道香潭村","registeredCapital":"15235万元","survey":" 浙江海森药业股份有限公司的主营业务是化学药品原料药及中间体研发、生产和销售。公司的主要产品是化学药品原料药、中间体。公司先后获得了浙江省“专精特新”中小企业,创新型中小企业,科技型中小企业,AAA级“守合同重信用”企业,第二批制造业“云上企业”;金华市优秀企业金星奖,专利示范企业;东阳市“工业强市贡献奖”,“纳税百强”,政府质量奖等荣誉称号。","listedPrice":44.48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海森药业(001367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海森药业(001367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海森药业,001367,海森药业股票,海森药业股票老虎,海森药业股票老虎国际,海森药业行情,海森药业股票行情,海森药业股价,海森药业股市,海森药业股票价格,海森药业股票交易,海森药业股票购买,海森药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海森药业(001367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海森药业(001367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}